193 related articles for article (PubMed ID: 23676114)
1. Intravenous anidulafungin followed optionally by oral voriconazole for the treatment of candidemia in Asian patients: results from an open-label Phase III trial.
Mootsikapun P; Hsueh PR; Talwar D; Co VM; Rajadhyaksha V; Ong ML
BMC Infect Dis; 2013 May; 13():219. PubMed ID: 23676114
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of an early step-down strategy from intravenous anidulafungin to oral azole therapy for the treatment of candidemia and other forms of invasive candidiasis: results from an open-label trial.
Vazquez J; Reboli AC; Pappas PG; Patterson TF; Reinhardt J; Chin-Hong P; Tobin E; Kett DH; Biswas P; Swanson R
BMC Infect Dis; 2014 Feb; 14():97. PubMed ID: 24559321
[TBL] [Abstract][Full Text] [Related]
3. Anidulafungin for the treatment of candidaemia/invasive candidiasis in selected critically ill patients.
Ruhnke M; Paiva JA; Meersseman W; Pachl J; Grigoras I; Sganga G; Menichetti F; Montravers P; Auzinger G; Dimopoulos G; Borges Sá M; Miller PJ; Marček T; Kantecki M
Clin Microbiol Infect; 2012 Jul; 18(7):680-7. PubMed ID: 22404732
[TBL] [Abstract][Full Text] [Related]
4. An open-label study of anidulafungin for the treatment of candidaemia/invasive candidiasis in Latin America.
Nucci M; Colombo AL; Petti M; Magana M; Abreu P; Schlamm HT; Sanchez SP
Mycoses; 2014 Jan; 57(1):12-8. PubMed ID: 23710653
[TBL] [Abstract][Full Text] [Related]
5. Invasive Candidiasis in Patients with Solid Tumors Treated with Anidulafungin: A Post Hoc Analysis of Efficacy and Safety of Six Pooled Studies.
De Rosa FG; Busca A; Capparella MR; Yan JL; Aram JA
Clin Drug Investig; 2021 Jun; 41(6):539-548. PubMed ID: 33891293
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of anidulafungin in 539 patients with invasive candidiasis: a patient-level pooled analysis of six clinical trials.
Kullberg BJ; Vasquez J; Mootsikapun P; Nucci M; Paiva JA; Garbino J; Yan JL; Aram J; Capparella MR; Conte U; Schlamm H; Swanson R; Herbrecht R
J Antimicrob Chemother; 2017 Aug; 72(8):2368-2377. PubMed ID: 28459966
[TBL] [Abstract][Full Text] [Related]
7. Anidulafungin for the treatment of candidaemia caused by Candida parapsilosis: Analysis of pooled data from six prospective clinical studies.
Kontoyiannis DP; Bassetti M; Nucci M; Capparella MR; Yan JL; Aram J; Hogan PA
Mycoses; 2017 Oct; 60(10):663-667. PubMed ID: 28597967
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of anidulafungin in the treatment of intra-abdominal candidiasis: a pooled analysis of patient-level data from 5 prospective studies.
Sganga G; Wang M; Capparella MR; Tawadrous M; Yan JL; Aram JA; Montravers P
Eur J Clin Microbiol Infect Dis; 2019 Oct; 38(10):1849-1856. PubMed ID: 31280481
[TBL] [Abstract][Full Text] [Related]
9. Bronchopulmonary disposition of intravenous voriconazole and anidulafungin given in combination to healthy adults.
Crandon JL; Banevicius MA; Fang AF; Crownover PH; Knauft RF; Pope JS; Russomanno JH; Shore E; Nicolau DP; Kuti JL
Antimicrob Agents Chemother; 2009 Dec; 53(12):5102-7. PubMed ID: 19770284
[TBL] [Abstract][Full Text] [Related]
10. Clinical experience of anidulafungin for the treatment of patients with documented candidemia.
Falcone M; Russo A; De Rosa FG; Pasero D; Toma L; Raponi G; Ghezzi MC; Venditti M
J Chemother; 2010 Dec; 22(6):397-401. PubMed ID: 21303747
[TBL] [Abstract][Full Text] [Related]
11. A multi-centric Study of Candida bloodstream infection in Lima-Callao, Peru: Species distribution, antifungal resistance and clinical outcomes.
Rodriguez L; Bustamante B; Huaroto L; Agurto C; Illescas R; Ramirez R; Diaz A; Hidalgo J
PLoS One; 2017; 12(4):e0175172. PubMed ID: 28419092
[TBL] [Abstract][Full Text] [Related]
12. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
13. Safety and pharmacokinetics of coadministered voriconazole and anidulafungin.
Dowell JA; Schranz J; Baruch A; Foster G
J Clin Pharmacol; 2005 Dec; 45(12):1373-82. PubMed ID: 16291712
[TBL] [Abstract][Full Text] [Related]
14. Anidulafungin compared with fluconazole for treatment of candidemia and other forms of invasive candidiasis caused by Candida albicans: a multivariate analysis of factors associated with improved outcome.
Reboli AC; Shorr AF; Rotstein C; Pappas PG; Kett DH; Schlamm HT; Reisman AL; Biswas P; Walsh TJ
BMC Infect Dis; 2011 Sep; 11():261. PubMed ID: 21961941
[TBL] [Abstract][Full Text] [Related]
15. Anidulafungin and voriconazole in invasive fungal disease: pharmacological data and their use in combination.
Perkhofer S; Lass-Flörl C
Expert Opin Investig Drugs; 2009 Sep; 18(9):1393-404. PubMed ID: 19656074
[TBL] [Abstract][Full Text] [Related]
16. Safety and tolerability of voriconazole in patients with baseline renal insufficiency and candidemia.
Oude Lashof AM; Sobel JD; Ruhnke M; Pappas PG; Viscoli C; Schlamm HT; Rex JH; Kullberg BJ
Antimicrob Agents Chemother; 2012 Jun; 56(6):3133-7. PubMed ID: 22450974
[TBL] [Abstract][Full Text] [Related]
17. Risk factors of mortality and comparative in-vitro efficacy of anidulafungin, caspofungin, and micafungin for candidemia.
Lee SC; Lee CW; Shih HJ; Huang SH; Chiou MJ; See LC
J Microbiol Immunol Infect; 2014 Jun; 47(3):245-53. PubMed ID: 24246191
[TBL] [Abstract][Full Text] [Related]
18. Anidulafungin compared with fluconazole in severely ill patients with candidemia and other forms of invasive candidiasis: support for the 2009 IDSA treatment guidelines for candidiasis.
Kett DH; Shorr AF; Reboli AC; Reisman AL; Biswas P; Schlamm HT
Crit Care; 2011; 15(5):R253. PubMed ID: 22026929
[TBL] [Abstract][Full Text] [Related]
19. Combined therapy of voriconazole and anidulafungin in murine infections by Aspergillus flavus.
Calvo E; Pastor FJ; Salas V; Mayayo E; Guarro J
Mycopathologia; 2012 Apr; 173(4):251-7. PubMed ID: 22139415
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and pharmacodynamics of voriconazole combined with anidulafungin in azole-resistant invasive aspergillosis.
Seyedmousavi S; Brüggemann RJ; Melchers WJ; Rijs AJ; Verweij PE; Mouton JW
J Antimicrob Chemother; 2013 Feb; 68(2):385-93. PubMed ID: 23129729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
